Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERα transcriptional activity and MCF-7 proliferation

Molecular Endocrinology

Volumn 16, Issue 2, 2002, Pages 253-270

  Cavarretta, Ilaria T R ^a,c   Mukopadhyay, Ratna ^a   Lonard, David M ^a   Cowsert, Lex M ^b   Bennett, C Frank ^b   O'Malley, Bert W ^a   Smith, Carolyn L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ISIS PHARMACEUTICALS   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ESTROGEN; MESSENGER RNA; STEROID RECEPTOR COACTIVATOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ER ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION; GENE INDUCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

NON-PROGRAMMATIC;

BLOTTING, WESTERN; CELL DIVISION; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; ESTROGENS; GENE EXPRESSION REGULATION; HELA CELLS; HISTONE ACETYLTRANSFERASES; HUMANS; NUCLEAR RECEPTOR COACTIVATOR 2; OLIGONUCLEOTIDES, ANTISENSE; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, UNTRANSLATED; SUBSTRATE SPECIFICITY; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0036159948     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.16.2.253     Document Type: Article

References (86)

1. Cross-talk between peptide growth factor and estrogen receptor signaling pathways
2. Nuclear receptors enhance our understanding of transcription regulation
3. The oestrogen receptor: From perception to mechanism
4. On the mechanism of DNA binding by nuclear hormone receptors: A structural and functional perspective
5. The progesterone receptor stimulates cell-free transcription by enhancing the formation of a stable preinitiation complex
6. A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor α is essential for transcriptional activation and interaction with the general transcription factor TFIIB
7. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization
8. Identification of two transactivation domains in the mouse oestrogen receptor
9. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens
10. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
11. The human estrogen receptor has two independent nonacidic transcriptional activation functions
12. Identification of constitutive and steroid-dependent transactivation domains in the mouse oestrogen receptor
13. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor co-activator
14. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors
15. Signal transduction and transcriptional regulation by glucocorticoid receptor-lexA fusion proteins
16. Regulation of gene expression by nuclear hormone receptors
17. Estrogen receptor interaction with co-activators and co-repressors
18. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex
19. A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor α coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA
20. Sharp, an inducible cofactor that integrates nuclear receptor repression and activation
21. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
22. Nuclear receptor coregulators: Cellular and molecular biology
23. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors
24. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
25. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
26. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2
27. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
28. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
29. TRAM-1, a novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1
30. A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity
31. Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor
32. Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor γ
33. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes
34. GRIP1, a transcriptional coactivator for the AF-2 trans-activation domain of steroid, thyroid, retinoid, and vitamin D receptors
35. Estrogen receptor activation function 1 works by binding p160 coactivator proteins
36. The receptor-associated coactivator 3 activates transcription through CREB-binding protein recruitment and autoregulation
37. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development
38. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene
39. The SRC family of nuclear receptor coactivators
40. Sensible use of antisense: How to use oligonucleotides as research tools
41. Pharmacology of antisense oligonucleotide inhibitors of protein expression
42. Distinct steady-state nuclear receptor coregulator complexes exist in vivo
43. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides
44. Facilitating oligonucleotide delivery: Helping antisense deliver on its promise
45. Antisense inhibition of oncogene expression
46. Role of RNase H in hybrid-arrested translation by antisense oligonucleotides
47. Selective elimination of mRNAs in vivo: Complementary oligodeoxynucleotides promote RNA degradation by an RNase H-like activity
48. Functions and structures of ribonuclease H enzymes
49. CpG motifs in bacterial DNA trigger direct B-cell activation
50. Selection of single-stranded DNA molecules that bind and inhibit human thrombin
51. Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures
52. RNA selection. Aptamers achieve the desired recognition
53. Binding of phosphorothioate oligodeoxynucleotides to basic fibroblast growth factor, recombinant soluble CD4, laminin and fibronectin is P-chirality independent
54. Phosphorothioate antisense oligodeoxynucleotides: Questions of specificity
55. Steroid receptor coactivator-1 is a histone acetyltransferase
56. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
57. High-efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes
58. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes
59. In vivo production of human factor VII in mice after intrasplenic implantation of primary fibroblasts transfected by receptor-mediated, adenovirus-augmented gene delivery
60. Hepatic gene therapy: Adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes
61. Analysis of chicken progesterone receptor function and phosphorylation using an adenovirus-mediated procedure for high efficiency DNA transfer
62. Proliferation, hormonal responsiveness, and estrogen receptor content of MDF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens
63. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
64. The 5′flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein
65. ERβ: Identification and characterization of a novel human estrogen receptor
66. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
67. Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone
68. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides
69. The coactivators p300 and CBP have different functions during the differentiation of F9 cells
70. Steroid receptor co-activator-1 mediates 1,25-dihydroxyvitamin D(3)-stimulated alkaline phosphatase in human osteosarcoma cells
71. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation
72. Steroid receptor induction of gene transcription: A two-step model
73. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen
74. Involvement of nuclear receptor coactivator SRC-1 in estrogen-dependent cell growth of MCF-7 cells
75. Allosteric modulation of estrogen receptor conformation by different estrogen response elements
76. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300
77. p300 is a component of an estrogen receptor coactivator complex
78. Antisense-mediated depletion of p300 in human cells leads to premature G1 exit and up-regulation of c-MYC
79. Altered expression of estrogen receptor coregulators during human breast tumorigenesis
80. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity
81. The 26S proteasome is required for estrogen receptor-α and coactivator turn-over and for efficient estrogen receptor-α transactivation
82. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: Discovery of peptide antagonists of estrogen receptors α and β
83. A membrane-filter technique for the detection of complementary DNA
84. Nucleotide sequence of a cDNA coding for mouse cyclophilin
85. Characterization of a fetal urogenital sinus mesenchymal cell line U4F: Secretion of a negative growth regulatory activity